Emerging Infectious Diseases (Oct 2015)

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure

  • Sandie Ménard,
  • Tanila Ben Haddou,
  • Arba Pramundita Ramadani,
  • Frédéric Ariey,
  • Xavier Iriart,
  • Johann Beghain,
  • Christiane Bouchier,
  • Benoit Witkowski,
  • Antoine Berry,
  • Odile Mercereau-Puijalon,
  • Françoise Benoit-Vical

DOI
https://doi.org/10.3201/eid2110.150682
Journal volume & issue
Vol. 21, no. 10
pp. 1733 – 1741

Abstract

Read online

Plasmodium falciparum resistance to artemisinin derivatives in Southeast Asia threatens global malaria control strategies. Whether delayed parasite clearance, which exposes larger parasite numbers to artemisinins for longer times, selects higher-grade resistance remains unexplored. We investigated whether long-lasting artemisinin pressure selects a novel multidrug-tolerance profile. Although 50% inhibitory concentrations for 10 antimalarial drugs tested were unchanged, drug-tolerant parasites showed higher recrudescence rates for endoperoxides, quinolones, and an antifolate, including partner drugs of recommended combination therapies, but remained susceptible to atovaquone. Moreover, the age range of intraerythrocytic stages able to resist artemisinin was extended to older ring forms and trophozoites. Multidrug tolerance results from drug-induced quiescence, which enables parasites to survive exposure to unrelated antimalarial drugs that inhibit a variety of metabolic pathways. This novel resistance pattern should be urgently monitored in the field because this pattern is not detected by current assays and represents a major threat to antimalarial drug policy.

Keywords